In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

EU rules for batch testing of medicinal products after BREXIT

by In2Pharma | Feb 28, 2019 | News

European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...

Recent Posts

  • Webinar Full FMD implementation
  • Food Supplements
  • Code of conduct GMH and CGR tightens the rules  
  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België